PanGenomic Health (XCNQ:NARA) EBIT per Share : C$-1.71 (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health EBIT per Share?

PanGenomic Health's EBIT per Share for the three months ended in Sep. 2024 was C$-0.15. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was C$-1.71.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PanGenomic Health's EBIT per Share or its related term are showing as below:

XCNQ:NARA's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8.55
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PanGenomic Health's EBIT for the three months ended in Sep. 2024 was C$-0.20 Mil.

PanGenomic Health EBIT per Share Historical Data

The historical data trend for PanGenomic Health's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health EBIT per Share Chart

PanGenomic Health Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

-3.39

-109.03

-14.65

PanGenomic Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial									-0.98	-0.25	-0.10	-1.21	-0.15

PanGenomic Health EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PanGenomic Health's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.929	/	0.200
=	-14.65

PanGenomic Health's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.197	/	1.280
=	-0.15

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.71

PanGenomic Health (XCNQ:NARA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PanGenomic Health EBIT per Share Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PanGenomic Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

LL3:Germany

Address

3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9

Website

https://www.pangenomic.com

PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

Executives

Kaidong Zhang	Senior Officer
Vincent Lum	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer

PanGenomic Health Headlines

No Headlines